By comparison to the wt-BRCA1 breast cancer cells, the mutant cells HCC1937 and MDA-MB-436 expressed higher level of survivin with reduced sensitivity to paclitaxel, indicating as decreased % killed [26]. This evidence concerns the gene BRCA1 and breast cancer.